Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Preptin Levels and Their Relationship With Insulin Resistance in Patients With Polycystic Ovary Syndrome

NCT07736079 is registered in ClinicalTrials.gov with GÜLDEN ANATACA as lead sponsor.

NCT NCT07736079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Preptin Levels and Their Relationship With Insulin Resistance in Patients With Polycystic Ovary Syndrome
Lead sponsor
GÜLDEN ANATACA
Phase
Observational
Overall status
Not yet recruiting
Start date
July 30, 2026
Completion date
September 30, 2026
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, polycystic ovary syndrome (pcos)